Immutep : Corporate Presentation -March 26, 2024 at 08:12 am EDT
Forward-Looking Statements The purpose of the presentation is to provide an update of the business of Immutep Limited ACN 009 237 889 . These slides have been...
Immutep Limited First In Class Lead Nature Reviews Drug Discovery Checkpoint Discovery Approval Timeline Chief Scientific Officer
Source: marketscreener.com